Adial Pharmaceuticals (ADIL) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-2.19
-1.59
-0.98
-0.38

Details

Expected EPS
-0.4
Actual EPS
-0.38
Surprise EPS
0.02
Surprise Percent
+5%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -0.38 per share for Q4 2024.

0 Comments

Share your thoughts